Milestone for Patient Safety: Inspital GmbH Receives Coveted MDR Certificate in Risk Class IIa for Surgical Suction Devices
Neuss, May 2026 – A groundbreaking success for Inspital GmbH at its Neuss location: After an intensive three-year audit and validation process, the company has officially received full certification under the European Medical Device Regulation (MDR EU 2017/745) in Risk Class IIa for its entire portfolio of surgical suction devices. With this successful certification, Inspital now joins an exclusive circle of very few medical device manufacturers worldwide who have mastered this rigorous regulatory marathon and fully meet the strict EU safety standards for active suction systems.
Three Years of Hard Work for Uncompromising Safety
The path to MDR certification in Class IIa is considered one of the greatest administrative and technical hurdles in the medical device industry in recent decades. Over a period of three years, all technical documentation, mechatronic safety architectures, and clinical evaluations of Inspital's suction devices (such as the mobile models in the SU60.10 series and the portable battery-powered SU60.06 systems) were thoroughly examined by a Notified Body.
Every single component – from the powerful oil-free piston pumps to the two-stage overflow and aerosol protection, through to the validated reprocessing cycles according to ISO 17664 – had to provide rigorous scientific and practical evidence that it effectively eliminates the risk of cross-contamination and tissue trauma in everyday OR use.
"This success is the result of outstanding teamwork over three intensive years," explains Inspital GmbH's management. "The MDR demands complete transparency and clinical evidence at the highest level from manufacturers. The fact that we now hold this certificate confirms our role as a technological pioneer and gives our partners in hospitals absolute certainty that they are investing in legally compliant and future-proof medical technology."
Pioneer Role in the Market: Inspital Closes the Supply Gap
Since the regulatory burden under the MDR is extremely high, many international manufacturers have withdrawn from the European market or are avoiding the complex procedure for Risk Class IIa. This is leading to noticeable shortages in many hospitals when procuring compliant OR equipment.
As one of the few remaining manufacturers able to demonstrate full Class IIa certification for surgical suction devices, Inspital ensures resilience and supply capability in healthcare. Hospital procurement teams and medical technicians benefit from the certified status through significant liability reduction and absolute audit security during regulatory inspections at the hospital.
"Made in Germany" as a Lived Quality Standard
The successful certification underscores Inspital GmbH's unwavering quality commitment. At the Neuss location, the "Made in Germany" distinction is lived every day – from the first design drawing through precise material selection to the strict 100% final inspection of every single device before delivery.
The recognition as an officially MDR-certified manufacturer is not an endpoint for Inspital, but rather a mandate to continue playing a decisive role in shaping the global quality standard in operating rooms. Through the integrated Post-Market Surveillance (PMS) system in Neuss, practical experience from hospitals will continue to flow directly into the continuous development of the systems – for maximum patient safety and operational excellence.
News Press
Here you will find current news about trade fairs, congresses, PR and other relevant topics.